Teleflex Inc (NYSE:TFX)
$ 177.26 -0.99 (-0.56%) Market Cap: 8.23 Bil Enterprise Value: 9.85 Bil PE Ratio: 35.24 PB Ratio: 1.84 GF Score: 89/100

Teleflex Inc at Jefferies London Healthcare Conference Transcript

Nov 15, 2022 / 02:40PM GMT
Release Date Price: $215.02 (+2.39%)
Matthew Charles Taylor
Jefferies LLC, Research Division - Equity Analyst

Matt Taylor, Jefferies analyst here with Teleflex, Liam Kelly, CEO; Larry Keusch, who heads the IR function; and John Hsu also in IR in the audience.

We've scheduled 30 minutes because of the weather, we're only going to do 10. I really wanted to turn up the heat on these guys. So just the hard-hitting questions from here out. Anyway, so we always start high level. So maybe just for folks that don't know, talk about Teleflex's strategy, how you've kind of constructed the portfolio, talk about some of the bits and pieces that you've put together to create some of these focus areas. And then what that does for your long-term growth and margin plans.

Liam J. Kelly
Teleflex Incorporated - Chairman, President & CEO

Yes. So we started with a core group of products within Teleflex. We began our journey in 2011. We were a diversified med tech company, and we became a pure-play medical device company.

Back then, our growth rate was anything from minus 1% to plus 1%. Gross

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot